Drug Profile
Zaltoprofen
Alternative Names: CN-100; Peon; Pyranoprofen; Soleton; ZC-102Latest Information Update: 02 Sep 2009
Price :
$50
*
At a glance
- Originator Nippon Chemiphar
- Developer Nippon Chemiphar; Zeria
- Class Antipyretics; Antirheumatics; Benzopyrans; Nonsteroidal anti-inflammatories; Propionic acids; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Inflammation; Musculoskeletal disorders; Pain; Rheumatic disorders
- No development reported Respiratory tract disorders
Most Recent Events
- 02 Sep 2009 No development reported - Preregistration for Respiratory tract disorders in Japan (PO)
- 14 Jun 2002 Preregistration for Respiratory tract disorders in Japan (PO)
- 26 Jul 2000 Phase-III clinical trials for Respiratory tract disorders in Japan (PO)